Clonal Dissemination of a CTX-M-15 β-Lactamase-Producing Escherichia coli Strain in the Paris Area, Tunis, and Bangui
Lavollay, M, Mamlouk, K, Frank, T, Akpabie, A, Burghoffer, B, Ben Redjeb, S, Bercion, R, Gautier, V, Arlet, G
Published in Antimicrobial Agents and Chemotherapy (01.07.2006)
Published in Antimicrobial Agents and Chemotherapy (01.07.2006)
Get full text
Journal Article
Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics
Ahn, D., Barzi, A., Miksad, R.A., Surinach, A., Corvino, F.A., Valderrama, A., Mamlouk, K., Pulgar, S., Bekaii-Saab, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2
Taplin, M.E, Chi, K.N, Chu, F, Cochran, J, Edenfield, W.J, Antonarakis, E.S, Emmenegger, U, Heath, E.I, Hussain, A, Njar, V.C, Koletsky, A, Lipsitz, D, Nordquist, L, Pili, R, Rettig, M, Sartor, O, Shore, N.D, Marrinucci, D, Mamlouk, K, Montgomery, B
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
Evaluation of a cefoxitin disk diffusion test for the routine detection of methicillin-resistant Staphylococcus aureus
Boutiba-Ben Boubaker, I., Ben Abbes, R., Ben Abdallah, H., Mamlouk, K, Mahjoubi, F, Kammoun, A, Hammami, A, Ben Redjeb, S.
Published in Clinical microbiology and infection (01.08.2004)
Published in Clinical microbiology and infection (01.08.2004)
Get full text
Journal Article
Modification of the Bu Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring
MAMLOUK, K, SARACINO, G, BERRYMAN, R. B, FAY, J. W, PINEIRO, L. A, VANCE, E. A, WHITE, M, SANDLER, I, AGURA, E. D
Published in Bone marrow transplantation (Basingstoke) (01.04.2005)
Published in Bone marrow transplantation (Basingstoke) (01.04.2005)
Get full text
Journal Article
Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993–2001
Boubaker, I. Boutiba-Ben, Ghozzi, R., Abdallah, H. Ben, Mamlouk, K., Kamoun, A., Redjeb, S. Ben
Published in Clinical microbiology and infection (01.07.2004)
Published in Clinical microbiology and infection (01.07.2004)
Get full text
Journal Article
735PReal-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics
Ahn, D, Barzi, A, Miksad, R A, Surinach, A, Corvino, F A, Valderrama, A, Mamlouk, K, Pulgar, S, Bekaii-Saab, T
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) ± 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy
Chen, L-T, Wang-Gillam, A., Shan, Y-S, Macarulla Mercade, T., Blanc, J.F., Hubner, R., Chiu, C-F, Schwartsmann, G., Siveke, J., Belanger, B., de Jong, F., Mamlouk, K., von Hoff, D.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Effects of nanoliposomal irinotecan (nal-IRI; MM-398) ± 5-fluorouracil and leucavorin (5-FU/LV) on quality of life (QoL) in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy: results from the phase 3 NAPOLI-1 study
Melisi, D., Siveke, J.T., Blanc, J., Von Hoff, D.D., Wang-Gillam, A., Chen, L., Becker, C., Mamlouk, K., De Jong, F., Hubner, R.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
242P Effects of nal-IRI (MM-398) 6 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine based therapy: Results from NAPOLI-1
Hubner, R., Cubillo, A., Blanc, J.-F., Melisi, D., von Hoff, D.D., Wang-Gillam, A., Chen, L.-T., Becker, C., Mamlouk, K., Belanger, B., Yang, Y., de Jong, F., Siveke, J.T.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
242P Effects of nal-IRI (MM-398) ± 5-fluorouracil on quality of life (QoL) of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine based therapy: Results from NAPOLI-1
Hubner, R., Cubillo, A., Blanc, J-F., Melisi, D., von Hoff, D.D., Wang-Gillam, A., Chen, L-T., Becker, C., Mamlouk, K., Belanger, B., Yang, Y., de Jong, F., Siveke, J.T.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: a phase 3 study of nal-IRI±5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy
Blanc, J.F., Hubner, R., Li, C-P, Wang-Gillam, A., Bodoky, G., Dean, A., Shan, Y-S, Jameson, G., Macarulla Mercade, T., Lee, K-H, Cunningham, D., Chiu, C-F, Schwartsmann, G., Braiteh, F., von Hoff, D., Chen, L-T, Mamlouk, K., de Jong, F., Siveke, J.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
O-004Effects of nal-IRI (MM-398) plus or minus 5-fluorouracil on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine
Hubner, R, Cubillo, A, Blanc, J-F, Melisi, D, Von Hoff, D, Wang-Gillam, A, Chen, L-T, Becker, C, Mamlouk, K, Belanger, B, Yang, Y, de Jong, F, Siveke, J
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
PD-023 Safety across subgroups in NAPOLI-1: a phase 3 study of nal-IRI (MM-398) ± 5-fluorouracil and leucovorin (5-FU/LV) versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
Chen, L.-T., Siveke, J., Wang-Gillam, A., Hubner, R., Pant, S., Dragovich, T., Chung, V., Chang, D., Ross, P., Cooray, P., Tebbutt, N., Franke, F., Belanger, B., Dhindsa, N., de Jong, F., Mamlouk, K., Von Hoff, D.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article